Work

Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

Year: 2020

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2020.08.061

Authors: Jonathan G. Stine, Nagambika Munaganuru, Abbey Barnard, Jennifer L. Wang, Kellee Kaulback, Curtis K. Argo, Siddarth Singh, Kathryn J. Fowler, Claude B. Sirlin, Rohit Loomba

Institutions: Pennsylvania State University, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, University of California San Diego, University of Chicago, University of Virginia

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, Foundation for the National Institutes of Health, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Gilead Sciences, Boehringer Ingelheim, Takeda Pharmaceutical Company, Siemens, National Institutes of Health, Allergan, National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences

Awards: G1316440902, G1370780335, G1494183008, G1622551803, G1820179381, G1893910623, G3041046821, G3062614921, G30650868, G4053089651, Novel IL-23 inhibitor for the treatment of alcohol associated liver disease, G5035097905, Epigenetic Regulation of Alcoholic Liver Fibrosis, G557714991, G7563732412, G833470438, San Diego Digestive Diseases Research Center, The role of IL-17 signaling in alcohol-induced HCC, Clinical Research on Nonalcoholic Fatty Liver Disease

OpenAlex ID: W3082261340

FWCI: 5.307

Cites: 42

Cited by: 281

Related to: 10